These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 15036654)
1. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells. Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654 [TBL] [Abstract][Full Text] [Related]
2. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481 [TBL] [Abstract][Full Text] [Related]
3. Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells. Yoon JH; Kim IJ; Kim H; Kim HJ; Jeong MJ; Ahn SG; Kim SA; Lee CH; Choi BK; Kim JK; Jung KY; Lee S; Kanai Y; Endou H; Kim DK Cancer Lett; 2005 May; 222(2):237-45. PubMed ID: 15863273 [TBL] [Abstract][Full Text] [Related]
5. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells. Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134 [TBL] [Abstract][Full Text] [Related]
6. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Verrey F Pflugers Arch; 2003 Feb; 445(5):529-33. PubMed ID: 12634921 [TBL] [Abstract][Full Text] [Related]
7. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. Yamauchi K; Sakurai H; Kimura T; Wiriyasermkul P; Nagamori S; Kanai Y; Kohno N Cancer Lett; 2009 Apr; 276(1):95-101. PubMed ID: 19058911 [TBL] [Abstract][Full Text] [Related]
8. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier. Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859 [TBL] [Abstract][Full Text] [Related]
10. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine. Atluri H; Talluri RS; Mitra AK Int J Pharm; 2008 Jan; 347(1-2):23-30. PubMed ID: 17686592 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. Shennan DB; Thomson J Oncol Rep; 2008 Oct; 20(4):885-9. PubMed ID: 18813831 [TBL] [Abstract][Full Text] [Related]
12. Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells. Fraga S; Pinho MJ; Soares-da-Silva P Amino Acids; 2005 Nov; 29(3):229-33. PubMed ID: 16027961 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. del Amo EM; Urtti A; Yliperttula M Eur J Pharm Sci; 2008 Oct; 35(3):161-74. PubMed ID: 18656534 [TBL] [Abstract][Full Text] [Related]
14. High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells. Soares-da-Silva P; Serrão MP Am J Physiol Renal Physiol; 2004 Aug; 287(2):F252-61. PubMed ID: 15271688 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan. Kühne A; Kaiser R; Schirmer M; Heider U; Muhlke S; Niere W; Overbeck T; Hohloch K; Trümper L; Sezer O; Brockmöller J Pharmacogenet Genomics; 2007 Jul; 17(7):505-17. PubMed ID: 17558306 [TBL] [Abstract][Full Text] [Related]
16. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells). Yamamoto A; Akanuma S; Tachikawa M; Hosoya K J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975 [TBL] [Abstract][Full Text] [Related]
17. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678 [TBL] [Abstract][Full Text] [Related]
18. Identification and functional characterization of a Na(+)-independent large neutral amino acid transporter (LAT2) on ARPE-19 cells. Gandhi MD; Pal D; Mitra AK Int J Pharm; 2004 May; 275(1-2):189-200. PubMed ID: 15081149 [TBL] [Abstract][Full Text] [Related]
19. Expression and function of LAT1, a neutral amino acid exchanger, in renal porcine epithelial cell line LLC-PK. Soares-da-Silva P; Serrão P; Fraga S; Pinho MJ Acta Physiol Scand; 2005 Sep; 185(1):71-8. PubMed ID: 16128699 [TBL] [Abstract][Full Text] [Related]
20. Characterization of amino acid transport system L in HTB-41 human salivary gland epidermoid carcinoma cells. Park NS; Kim SG; Kim HK; Moon SY; Kim CS; Cho SH; Kanai Y; Endou H; Kim DK Anticancer Res; 2008; 28(5A):2649-55. PubMed ID: 19035290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]